Literature DB >> 664736

The role of staging laparotomy in combined modality therapy of Hodgkins disease: A new treatment plan based on a 6-year experience.

R E Wilson, R T Osteen, D S Rosenthal, P M Mauch, R L Goodman.   

Abstract

Entities:  

Mesh:

Year:  1978        PMID: 664736     DOI: 10.1007/BF01574473

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  11 in total

1.  Maximum utilization of the life table method in analyzing survival.

Authors:  S J CUTLER; F EDERER
Journal:  J Chronic Dis       Date:  1958-12

2.  Long term remissions with combined modality therapy for advanced Hodgkin's disease.

Authors:  L R Prosnitz; L R Farber; J J Fischer; J R Bertino; D B Fischer
Journal:  Cancer       Date:  1976-06       Impact factor: 6.860

3.  Can pelvic irradiation be omitted in patients with pathologic stages IA and IIA Hodgkin's disease?

Authors:  R L Goodman; A J Piro; S Hellman
Journal:  Cancer       Date:  1976-06       Impact factor: 6.860

4.  Combination chemotherapy and radiotherapy for Hodgkin's disease.

Authors:  S A Rosenberg; M R Moore; J M Bull; S E Jones; H S Kaplan
Journal:  Cancer       Date:  1972-12       Impact factor: 6.860

5.  Sequential radiotherapy and chemotherapy in the treatment of Hodgkin's disease. A progress report.

Authors:  M R Moore; J M Bull; S E Jones; S A Rosenberg; H S Kaplan
Journal:  Ann Intern Med       Date:  1972-07       Impact factor: 25.391

6.  The influence of laparotomy on management decisions in Hodgkin's disease.

Authors:  A J Piro; S Hellman; W C Moloney
Journal:  Arch Intern Med       Date:  1972-12

7.  Treatment of Hodgkin's disease using intensive chemotherapy followed by irradiation.

Authors:  L E Kun; V T DeVita; R C Young; R E Johnson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1976 Jul-Aug       Impact factor: 7.038

8.  The management of stages I, II, and III Hodgkin's disease with combined radiotherapy and chemotherapy.

Authors:  S A Rosenberg; H S Kaplan
Journal:  Cancer       Date:  1975-01       Impact factor: 6.860

9.  Stages IIB and IIIB Hodgkin's disease. Results of combined modality treatment.

Authors:  R Goodman; P Mauch; A Piro; D Rosenthal; M Goldstein; J Tullis; S Hellman
Journal:  Cancer       Date:  1977-07       Impact factor: 6.860

10.  Second malignancies complicating Hodgkin's disease in remission.

Authors:  G P Canellos; J C Arseneau; V T DeVita; J Whang-Peng; R E Johnson
Journal:  Lancet       Date:  1975-04-26       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.